RICHMOND, British Columbia, Aug. 25, 2011 (GLOBE NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) -- today announced that the Review Board for the 39th Annual Meeting of the International Society for Oncology and Biomarkers (ISOBM), has accepted two presentations on recent advances using BioCurex’s novel Pepto-RECAFTM peptide technology. These presentations, taking place in Florence, Italy, will describe the discovery process for the peptide as well as the rationale for utilizing a synthetic peptide as a superior alternative to an antibody in commercial versions of the RECAF™ blood test for cancer.
